[Federal Register Volume 65, Number 33 (Thursday, February 17, 2000)]
[Notices]
[Page 8206]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-3731]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on September 29, 1999, Ansys 
Diagnostics, Inc., 25200 Commercentre Drive, Lake Forest, California 
92630, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                            Drug                               Schedule
------------------------------------------------------------------------
Phencyclidine (7471)........................................         II
1-Piperidinocyclohexane- carbonitrile (PCC) (8603)..........         II
Benzoylecgonine (9180)......................................         II
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances to 
produce standards and controls for in-vitro diagnostic drug testing 
systems.
    Any other such application and any person who is presently 
registered with DEA to manufacture such substances may file comments or 
objections to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than April 17, 2000.

    Dated: February 10, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-3731 Filed 2-16-00; 8:45 am]
BILLING CODE 4410-09-M